NextCure, Inc.
NXTC
$12.32
$0.363.01%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -0.34% | 0.87% | 0.57% | 22.30% | 11.27% |
| Total Depreciation and Amortization | -23.73% | -17.28% | -18.40% | -22.34% | -22.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -58.51% | -50.15% | -45.54% | -40.21% | -6.91% |
| Change in Net Operating Assets | -78.95% | -15.10% | -111.18% | -47.99% | 333.61% |
| Cash from Operations | -21.59% | -9.97% | -18.11% | 18.91% | 22.97% |
| Capital Expenditure | -- | 106.53% | 78.41% | 28.24% | 42.20% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -54.18% | -50.07% | -19.63% | 13.41% | 39.13% |
| Cash from Investing | -53.79% | -49.51% | -18.80% | 14.06% | 40.83% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 16,243.75% | 1,055.06% | 1,055.06% | -7.74% | -6.49% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 15,394.44% | 1,055.06% | 1,055.06% | -7.74% | -6.49% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -111.92% | -349.05% | -1,262.60% | 129.87% | 208.10% |